Augmented Intense Pulse Light therapy may improve Meibomian gland dysfunction and dry eye disease
Sandy Zhang-Nunes and colleagues discovered that intense pulsed light (IPL) has shown great potential in the treatment of refractory Meibomian gland dysfunction (MGD) dry eye disease in a new research. This innovative IPL/ BroadBand Light (BBL™)/ strategy appears to be both safe and effective in the treatment of dry eye and blepharitis. The findings of this study were published in the journal of Photobiomodulation, Photomedicine, and Laser Surgery.
DED, which is frequently coupled with MGD, can cause severe morbidity and accounts for $3.54 billion in health-care costs in the United States each year. With some effectiveness, IPL has been used to treat MGD DED. BBL therapy, which uses high-quality IPL equipment, has a lot of promise for reducing inflammation and redness in rosacea, as well as hyperpigmentation caused by sun exposure.
The purpose of this research was to determine the safety and efficacy of an enhanced BroadBand Light (BBLTM) treatment on the upper and lower eyelids in treating Meibomian gland dysfunction (MGD) and/or dry eye illness (DED). A retrospective medical chart analysis was conducted for MGD DED and/or hyperpigmentation patients who had BBL treatment between January 1, 2015, and February 28, 2020, for this research. Patients who had at least one BBL therapy were eligible for inclusion. The upper and lower eyelids, as well as the cheekbones, nose, and face, were all treated. Each MGD DED patient completed the Ocular Surface Disease Index (OSDI) and performed normal clinical tests before and after therapy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.